During the past decade, Allegheny Ophthalmic & Orbital Associates, PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allegheny Ophthalmic & Orbital Associates, PC" are "Exudative Age-Related Macular Degeneration" (1 trials), "Focal Vitreomacular Adhesion" (1 trials), "Glaucoma" (1 trials), "Vitrectomy" (1 trials) and "Vitreomacular Adhesion" (1 trials). Many other conditions were trialed in "Allegheny Ophthalmic & Orbital Associates, PC" in a lesser frequency.

Most popular intervention types in "Allegheny Ophthalmic & Orbital Associates, PC" are "Drug" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "125 µg Ocriplasmin" (1 trials), "Ex-PRESS mini shunt" (1 trials), "Ocriplasmin" (1 trials) and "Ocriplasmin 125µg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny Ophthalmic & Orbital Associates, PC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Allegheny Ophthalmic & Orbital Associates, PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Allegheny Ophthalmic & Orbital Associates, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny Ophthalmic & Orbital Associates, PC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".